KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) EBT: 2017-2025

Historic EBT for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to -$187.0 million.

  • Moderna's EBT fell 990.48% to -$187.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 billion, marking a year-over-year decrease of 34.00%. This contributed to the annual value of -$3.6 billion for FY2024, which is 8.50% up from last year.
  • Moderna's EBT amounted to -$187.0 million in Q3 2025, which was up 77.14% from -$818.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's EBT registered a high of $5.4 billion during Q4 2021, and its lowest value of -$2.0 billion during Q3 2023.
  • For the 3-year period, Moderna's EBT averaged around -$865.3 million, with its median value being -$964.0 million (2025).
  • Per our database at Business Quant, Moderna's EBT skyrocketed by 2,717.95% in 2021 and then slumped by 1,791.43% in 2024.
  • Over the past 5 years, Moderna's EBT (Quarterly) stood at $5.4 billion in 2021, then plummeted by 69.41% to $1.7 billion in 2022, then crashed by 95.77% to $70.0 million in 2023, then plummeted by 1,791.43% to -$1.2 billion in 2024, then plummeted by 990.48% to -$187.0 million in 2025.
  • Its EBT was -$187.0 million in Q3 2025, compared to -$818.0 million in Q2 2025 and -$964.0 million in Q1 2025.